AQR Capital Management
SWAV

AQR Capital Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

AQR Capital Management’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,360
Closed -$636K – 2526
2023
Q4 		$636K Sell
3,360
-23,464
-87% -$4.43M ﹤0.01% 1783
2023
Q3 		$5.34M Sell
26,824
-8,717
-25% -$2.06M 0.01% 896
2023
Q2 		$10.1M Sell
35,541
-24,307
-41% -$6.75M 0.02% 662
2023
Q1 		$13M Buy
59,848
+34,484
+136% +$6.72M 0.03% 598
2022
Q4 		$5.14M Buy
25,364
+4,248
+20% +$1.07M 0.01% 873
2022
Q3 		$5.87M Buy
21,116
+13,966
+195% +$3.55M 0.01% 795
2022
Q2 		$1.37M Sell
7,150
-10,692
-60% -$1.89M ﹤0.01% 1290
2022
Q1 		$3.7M Buy
17,842
+2,823
+19% +$465K 0.01% 925
2021
Q4 		$2.68M Sell
15,019
-2,172
-13% -$428K ﹤0.01% 1017
2021
Q3 		$3.54M Buy
17,191
+7,564
+79% +$1.49M 0.01% 905
2021
Q2 		$1.83M Buy
+9,627
New +$1.58M ﹤0.01% 1266

Other funds holding SWAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AQR Capital Management's SWAV Position: Q1 2024 in Review

AQR Capital Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2024, closing a stake of 3,360 shares — an estimated $636K sold.

AQR Capital Management first reported a position in SWAV in Q2 2021 and held it in 11 quarters. The position peaked at $13M in Q1 2023. 488 funds tracked by Wall St. Rank hold SWAV as of Q1 2024.

  • AQR Capital Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • AQR Capital Management sold 3,360 Shockwave Medical, Inc. Common Stock shares in Q1 2024, an estimated $636K.
  • AQR Capital Management first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2021 and held it in 11 quarters.
  • AQR Capital Management's Shockwave Medical, Inc. Common Stock position peaked at $13M in Q1 2023.
  • 488 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2024.

Based on AQR Capital Management's 13F filing for Q1 2024, filed 15 May 2024.